NasdaqGM - Nasdaq Real Time Price USD

Silexion Therapeutics Corp (SLXN)

Compare
3.5200 +0.1800 (+5.39%)
At close: December 13 at 4:00:00 PM EST
3.5200 0.00 (0.00%)
After hours: 7:16:32 PM EST

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Ms. Mirit Horenshtein Hadar EVP of Finance Affairs, CFO & Secretary 69.98k -- 1984
Dr. Mitchell Shirvan M.B.A., Ph.D. Chief Scientific & Development Officer 206.8k -- 1954

Silexion Therapeutics Corp

The Goldyne Savad Institute of Gene Therapy
Hadassah Hebrew University Medical Center
Jerusalem, 9112001
Israel
972 2 674 3430 https://silexion.com
Sector: 
Healthcare
Industry: 
Biotechnology

Description

Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. The company was founded in 2008 and is headquartered in Jerusalem, Israel.

Corporate Governance

Silexion Therapeutics Corp’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 12, 2024 at 9:00 PM UTC - November 18, 2024 at 9:00 PM UTC

Silexion Therapeutics Corp Earnings Date

Recent Events

Related Tickers

PCSA Processa Pharmaceuticals, Inc.
1.1100
-11.20%
 
PBM Psyence Biomedical Ltd.
1.8500
-9.31%
 
PALI Palisade Bio, Inc.
1.7700
-25.00%
 
CRDF Cardiff Oncology, Inc.
3.9200
+19.88%
 
SONN Sonnet BioTherapeutics Holdings, Inc.
1.8100
+2.26%
 
TRVI Trevi Therapeutics, Inc.
4.1700
+15.83%
 
IPHA Innate Pharma S.A.
3.0200
+96.10%
 
CDIO Cardio Diagnostics Holdings, Inc.
1.2600
+5.00%
 
CMRX Chimerix, Inc.
2.9500
+0.34%
 
DBVT DBV Technologies S.A.
3.5700
-7.03%